(Total Views: 375)
Posted On: 07/15/2020 9:02:54 AM
Post# of 36566
In anwer to your question about how is NGIO (ii-key) different:
1.NGIO is a synthetic peptide vaccine that can be produced very quickly in mass quantities. It is not grown in animal cells like most other peptide vaccines.
2. NGIO is a complete vaccine with both neutralizing antibodies and a T-cell response. This makes it safer and reduces chances of a cytokine storm.
From a recent PR:
1.NGIO is a synthetic peptide vaccine that can be produced very quickly in mass quantities. It is not grown in animal cells like most other peptide vaccines.
2. NGIO is a complete vaccine with both neutralizing antibodies and a T-cell response. This makes it safer and reduces chances of a cytokine storm.
From a recent PR:
Quote:
This standard protocol, which has been developed over the years by the NuGenerex Immuno-Oncology team, enables us to identify specific coronavirus peptide epitopes that produce neutralizing, rather than off-target antibodies, and activate appropriate T-helper cell (TH1) responses through the Ii-Key rather than the potentially dangerous TH2 responses that are part of the cytokine storm. In this fashion, we can not only select the proper, specific epitopes for a peptide vaccine, but we also test the specificity of the immune response generated by our Ii-Key-SARS-CoV-2 peptide vaccine in a 100% safe “Ex-Vivo” human clinical trial before we proceed to the clinic.
(0)
(0)
